MirZyme Therapeutics offers the end-to-end preeclampsia solution. It is an early-stage clinical women's health biopharmaceutical company that has uncovered what causes preeclampsia and how to predict and prevent it. We have a pipeline of tailored therapeutics to prevent preeclampsia and Small for Gestational Age babies.
Our digital diagnostic algorithm takes blood test results and tells a pregnant woman half way through pregnancy if she is going to develop preeclampsia.
MirZyme has a highly skilled, diverse, and deeply dedicated team. The core team have worked together for over a decade.